42.84 USD
+0.62 (+1.47%)
42.84 USD
0 (0%)
Taking everything into account, VCYT scores 6 out of 10 in our fundamental rating. VCYT was compared to 531 industry peers in the Biotechnology industry. VCYT has an excellent financial health rating, but there are some minor concerns on its profitability. VCYT is not priced too expensively while it is growing strongly. Keep and eye on this one! This makes VCYT very considerable for growth investing!
1. Profitability
1.1 Basic Checks
In the past year VCYT was profitable.
VCYT had a positive operating cash flow in the past year.
VCYT had negative earnings in 4 of the past 5 years.
In multiple years VCYT reported negative operating cash flow during the last 5 years.
1.2 Ratios
VCYT has a better Return On Assets (2.22%) than 89.08% of its industry peers.
With an excellent Return On Equity value of 2.41%, VCYT belongs to the best of the industry, outperforming 90.21% of the companies in the same industry.
With an excellent Return On Invested Capital value of 2.93%, VCYT belongs to the best of the industry, outperforming 89.83% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.22% | ||
| ROE | 2.41% | ||
| ROIC | 2.93% |
ROA(3y)-2.66%
ROA(5y)-4.4%
ROE(3y)-2.83%
ROE(5y)-4.73%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
VCYT's Profit Margin of 6.12% is amongst the best of the industry. VCYT outperforms 90.02% of its industry peers.
VCYT's Operating Margin of 9.70% is amongst the best of the industry. VCYT outperforms 91.53% of its industry peers.
The Gross Margin of VCYT (68.53%) is better than 80.98% of its industry peers.
VCYT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.7% | ||
| PM (TTM) | 6.12% | ||
| GM | 68.53% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.39%
GM growth 5Y-0.79%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), VCYT is destroying value.
The number of shares outstanding for VCYT has been increased compared to 1 year ago.
The number of shares outstanding for VCYT has been increased compared to 5 years ago.
There is no outstanding debt for VCYT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
VCYT has an Altman-Z score of 18.56. This indicates that VCYT is financially healthy and has little risk of bankruptcy at the moment.
VCYT's Altman-Z score of 18.56 is amongst the best of the industry. VCYT outperforms 87.95% of its industry peers.
VCYT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 18.56 |
ROIC/WACC0.33
WACC8.78%
2.3 Liquidity
VCYT has a Current Ratio of 6.23. This indicates that VCYT is financially healthy and has no problem in meeting its short term obligations.
VCYT's Current ratio of 6.23 is fine compared to the rest of the industry. VCYT outperforms 64.22% of its industry peers.
VCYT has a Quick Ratio of 5.94. This indicates that VCYT is financially healthy and has no problem in meeting its short term obligations.
VCYT's Quick ratio of 5.94 is fine compared to the rest of the industry. VCYT outperforms 63.09% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.23 | ||
| Quick Ratio | 5.94 |
3. Growth
3.1 Past
VCYT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 353.33%, which is quite impressive.
VCYT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.41%.
The Revenue has been growing by 29.93% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)353.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.32%
Revenue 1Y (TTM)16.41%
Revenue growth 3Y26.64%
Revenue growth 5Y29.93%
Sales Q2Q%13.82%
3.2 Future
Based on estimates for the next years, VCYT will show a very strong growth in Earnings Per Share. The EPS will grow by 52.24% on average per year.
Based on estimates for the next years, VCYT will show a quite strong growth in Revenue. The Revenue will grow by 11.54% on average per year.
EPS Next Y74.53%
EPS Next 2Y86.75%
EPS Next 3Y59.6%
EPS Next 5Y52.24%
Revenue Next Year14.36%
Revenue Next 2Y12.54%
Revenue Next 3Y12.19%
Revenue Next 5Y11.54%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 112.74, the valuation of VCYT can be described as expensive.
VCYT's Price/Earnings ratio is rather cheap when compared to the industry. VCYT is cheaper than 89.45% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.54, VCYT is valued quite expensively.
A Price/Forward Earnings ratio of 40.95 indicates a quite expensive valuation of VCYT.
Compared to the rest of the industry, the Price/Forward Earnings ratio of VCYT indicates a rather cheap valuation: VCYT is cheaper than 91.34% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of VCYT to the average of the S&P500 Index (23.78), we can say VCYT is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 112.74 | ||
| Fwd PE | 40.95 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of VCYT indicates a rather cheap valuation: VCYT is cheaper than 91.15% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, VCYT is valued cheaply inside the industry as 93.41% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 34.48 | ||
| EV/EBITDA | 41.49 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of VCYT may justify a higher PE ratio.
A more expensive valuation may be justified as VCYT's earnings are expected to grow with 59.60% in the coming years.
PEG (NY)1.51
PEG (5Y)N/A
EPS Next 2Y86.75%
EPS Next 3Y59.6%
5. Dividend
5.1 Amount
No dividends for VCYT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
42.84
+0.62 (+1.47%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners114.7%
Inst Owner Change3.31%
Ins Owners0.46%
Ins Owner Change-2.17%
Market Cap3.39B
Revenue(TTM)495.14M
Net Income(TTM)30.32M
Analysts82.11
Price Target49.33 (15.15%)
Short Float %6.93%
Short Ratio5.71
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-15.65%
Min EPS beat(2)-110.32%
Max EPS beat(2)79.03%
EPS beat(4)2
Avg EPS beat(4)-1.91%
Min EPS beat(4)-110.32%
Max EPS beat(4)79.03%
EPS beat(8)5
Avg EPS beat(8)108.97%
EPS beat(12)8
Avg EPS beat(12)67.3%
EPS beat(16)12
Avg EPS beat(16)58.01%
Revenue beat(2)2
Avg Revenue beat(2)4.54%
Min Revenue beat(2)3.31%
Max Revenue beat(2)5.76%
Revenue beat(4)3
Avg Revenue beat(4)2.42%
Min Revenue beat(4)-0.39%
Max Revenue beat(4)5.76%
Revenue beat(8)7
Avg Revenue beat(8)4.03%
Revenue beat(12)11
Avg Revenue beat(12)4.6%
Revenue beat(16)15
Avg Revenue beat(16)5.32%
PT rev (1m)14.88%
PT rev (3m)17.32%
EPS NQ rev (1m)8.52%
EPS NQ rev (3m)14.94%
EPS NY rev (1m)31.06%
EPS NY rev (3m)39.68%
Revenue NQ rev (1m)0.11%
Revenue NQ rev (3m)0.48%
Revenue NY rev (1m)1.31%
Revenue NY rev (3m)1.6%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 112.74 | ||
| Fwd PE | 40.95 | ||
| P/S | 6.84 | ||
| P/FCF | 34.48 | ||
| P/OCF | 31.28 | ||
| P/B | 2.69 | ||
| P/tB | 8.51 | ||
| EV/EBITDA | 41.49 |
EPS(TTM)0.38
EY0.89%
EPS(NY)1.05
Fwd EY2.44%
FCF(TTM)1.24
FCFY2.9%
OCF(TTM)1.37
OCFY3.2%
SpS6.26
BVpS15.91
TBVpS5.04
PEG (NY)1.51
PEG (5Y)N/A
Graham Number11.66
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.22% | ||
| ROE | 2.41% | ||
| ROCE | 3.71% | ||
| ROIC | 2.93% | ||
| ROICexc | 4.08% | ||
| ROICexgc | 54.52% | ||
| OM | 9.7% | ||
| PM (TTM) | 6.12% | ||
| GM | 68.53% | ||
| FCFM | 19.83% |
ROA(3y)-2.66%
ROA(5y)-4.4%
ROE(3y)-2.83%
ROE(5y)-4.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.39%
GM growth 5Y-0.79%
F-Score8
Asset Turnover0.36
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 44.87% | ||
| Cap/Sales | 2.03% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 153.79% | ||
| Profit Quality | 323.94% | ||
| Current Ratio | 6.23 | ||
| Quick Ratio | 5.94 | ||
| Altman-Z | 18.56 |
F-Score8
WACC8.78%
ROIC/WACC0.33
Cap/Depr(3y)39.24%
Cap/Depr(5y)36.19%
Cap/Sales(3y)2.72%
Cap/Sales(5y)2.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)353.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.32%
EPS Next Y74.53%
EPS Next 2Y86.75%
EPS Next 3Y59.6%
EPS Next 5Y52.24%
Revenue 1Y (TTM)16.41%
Revenue growth 3Y26.64%
Revenue growth 5Y29.93%
Sales Q2Q%13.82%
Revenue Next Year14.36%
Revenue Next 2Y12.54%
Revenue Next 3Y12.19%
Revenue Next 5Y11.54%
EBIT growth 1Y426.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year319.96%
EBIT Next 3Y74.15%
EBIT Next 5Y47.08%
FCF growth 1Y237.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y181.75%
OCF growth 3YN/A
OCF growth 5YN/A
VERACYTE INC / VCYT FAQ
What is the fundamental rating for VCYT stock?
ChartMill assigns a fundamental rating of 6 / 10 to VCYT.
What is the valuation status for VCYT stock?
ChartMill assigns a valuation rating of 6 / 10 to VERACYTE INC (VCYT). This can be considered as Fairly Valued.
How profitable is VERACYTE INC (VCYT) stock?
VERACYTE INC (VCYT) has a profitability rating of 6 / 10.
How financially healthy is VERACYTE INC?
The financial health rating of VERACYTE INC (VCYT) is 8 / 10.
What is the expected EPS growth for VERACYTE INC (VCYT) stock?
The Earnings per Share (EPS) of VERACYTE INC (VCYT) is expected to grow by 74.53% in the next year.